肿瘤药物加速审批计划：庆祝获得超过 25 万的生命年数，且这一数字还在不断增加。
The accelerated approval program for oncology drugs: celebrating more than 250,000 life-years gained and counting.
机构信息
National Pharmaceutical Council, 717 Pennsylvania Ave NW, Ste 800, Washington, DC 20006. Email:
出版信息
Am J Manag Care. 2024 Aug 1;30(8):e223-e225. doi: 10.37765/ajmc.2024.89590.
PMID:39146478
Abstract
This commentary explores how 2 recently published studies evaluating the clinical benefit of the FDA's accelerated approval program for oncology drugs came to different conclusions.
摘要
本评论探讨了最近发表的两项研究如何得出了不同的结论，这两项研究评估了 FDA 加速批准肿瘤药物计划的临床获益。
Zotero 插件